Actively Recruiting

Phase 4
Age: 18Years - 65Years
All Genders
ID05305313

Evaluation of Propofol Dosing Based on Total Body Weight Versus Adjusted Body Weight in Obese Patients Receiving Total Intravenous Anaesthesia Using an Automated Closed-Loop Anaesthesia Delivery System: A Randomized Controlled Study

Led by Sir Ganga Ram Hospital · Updated on 2026-04-27

46

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating how different methods of calculating propofol dosing affect anesthesia in obese patients. Propofol is a common intravenous anesthetic used for induction and maintenance during surgery. Obesity changes how drugs are processed in the body, making dosing challenging. This study compares dosing based on total body weight (TBW) to adjusted body weight (ABW) to see which approach better controls anesthesia without overdosing or delayed recovery. The study uses a computer-controlled closed-loop anesthesia delivery system (CLADS) that adjusts propofol infusion based on brain electrical activity measured by bispectral index (BIS). Patients are randomly assigned to receive propofol dosing calculated either by TBW or ABW during surgery lasting more than 60 minutes. A BIS target value of 50 guides anesthesia depth, with propofol delivered continuously via an automated pump during the procedure. Participants will undergo standard assessments including monitoring of anesthesia depth, heart rate, blood pressure, and recovery after surgery. The primary outcome is the maintenance dose of propofol required during anesthesia. Secondary outcomes include consistency of anesthesia depth, system performance, early recovery, sedation levels, and intraoperative awareness. The study involves adult obese patients up to age 65 undergoing laparoscopic or non-laparoscopic surgery. Safety and drug effects are closely monitored from anesthesia start until 48 hours after surgery.

CONDITIONS

Brief Title

Evaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia Delivery System

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • ASA physical status II or III
  • Undergoing laparoscopic or non-laparoscopic surgery lasting more than 60 minutes
  • Body mass index greater than 35 kg/m2
  • Age between 18 and 65 years
Not Eligible

You will not qualify if you...

  • Cardiovascular disorders including uncontrolled hypertension, atrioventricular block, sinus bradycardia, congenital heart disease, or reduced left ventricular compliance and diastolic dysfunction
  • Neurological disorders such as previous neurosurgery, psychiatric disorders, or autonomic nervous system disorders like orthostatic hypotension or transient ischemic attacks
  • Liver or kidney insufficiency
  • Uncontrolled diabetes mellitus
  • Known allergy or hypersensitivity to propofol
  • Pulmonary dysfunction including restrictive or obstructive lung disease
  • Acute or chronic drug dependence or substance abuse

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - From start of anesthesia until 5 minutes after skin closure

Participants receive anesthesia induced and maintained with Propofol administered by an automated closed-loop anesthesia delivery system (CLADS), which controls propofol delivery rate to maintain a consistent anesthetic depth (BIS=50). Dosing is based on either total body weight (TBW) or adjusted body weight (ABW) depending on group assignment.

1 anesthesia session (in-person)

Follow-up

Duration - Up to 48 hours post-anesthesia

Participants are monitored for early recovery from anesthesia, postoperative sedation, and intraoperative awareness.

Visits or assessments up to 48 hours after anesthesia

Trial Site Locations

Total: 1 location

1

Nitin Sethi

New Delhi, National Capital Territory of Delhi, India, 110060

Actively Recruiting

Loading map...

Research Team

N

Nitin Sethi, DNB

A

Amitabh Dutta, MD, PGDHR

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Similar Trials

2024 NewAnescat Register

Anesthesia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here